Holen Sie sich die Stockscreener-App
110.17
1.32%
1.43
Handel nachbörslich:
109.00
-1.17
-1.06%
Schlusskurs vom Vortag:
$108.74
Offen:
$108.17
24-Stunden-Volumen:
2.40M
Relative Volume:
0.97
Marktkapitalisierung:
$14.31B
Einnahmen:
$692.26M
Nettoeinkommen (Verlust:
$-512.41M
KGV:
-25.98
EPS:
-4.24
Netto-Cashflow:
$-274.36M
1W Leistung:
+8.29%
1M Leistung:
+6.74%
6M Leistung:
+115.85%
1J Leistung:
+201.09%
1-Tages-Spanne:
$106.97
$112.40
1-Wochen-Bereich:
$97.31
$113.91
52-Wochen-Spanne:
$34.80
$113.91
Guardant Health Inc Stock (GH) Company Profile
Firmenname
Guardant Health Inc
Sektor
Branche
Telefon
855-698-8887
Adresse
3100 HANOVER STREET, PALO ALTO
Vergleichen Sie GH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GH
Guardant Health Inc
|
110.17 | 14.12B | 692.26M | -512.41M | -274.36M | -4.24 |
|
TMO
Thermo Fisher Scientific Inc
|
618.86 | 227.87B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
238.37 | 165.99B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
713.35 | 56.89B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
148.52 | 41.32B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
242.41 | 41.42B | 15.90B | 1.28B | 2.21B | 7.2842 |
Guardant Health Inc Stock (GH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-05 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-09-25 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-09-22 | Fortgesetzt | Wells Fargo | Overweight |
| 2025-04-10 | Eingeleitet | Mizuho | Outperform |
| 2025-01-23 | Eingeleitet | Barclays | Overweight |
| 2024-06-28 | Hochstufung | Guggenheim | Neutral → Buy |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-04-24 | Fortgesetzt | Craig Hallum | Buy |
| 2023-12-14 | Eingeleitet | Guggenheim | Neutral |
| 2023-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2023-11-13 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-09-27 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-05-26 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-05-05 | Eingeleitet | UBS | Buy |
| 2023-03-09 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-11-01 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-10-19 | Eingeleitet | Craig Hallum | Buy |
| 2022-10-06 | Eingeleitet | Stephens | Overweight |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-06-03 | Eingeleitet | Piper Sandler | Overweight |
| 2022-04-28 | Fortgesetzt | BTIG Research | Buy |
| 2022-02-24 | Bestätigt | Canaccord Genuity | Buy |
| 2022-02-24 | Bestätigt | Citigroup | Buy |
| 2022-02-24 | Bestätigt | Cowen | Outperform |
| 2022-02-24 | Bestätigt | Morgan Stanley | Overweight |
| 2022-02-24 | Bestätigt | SVB Leerink | Outperform |
| 2022-02-24 | Bestätigt | Stifel | Buy |
| 2022-02-24 | Bestätigt | Wells Fargo | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-15 | Eingeleitet | Raymond James | Mkt Perform |
| 2021-06-03 | Eingeleitet | Goldman | Buy |
| 2021-05-25 | Eingeleitet | Wells Fargo | Overweight |
| 2021-01-11 | Eingeleitet | Stifel | Buy |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-06-12 | Eingeleitet | BTIG Research | Buy |
| 2020-02-21 | Eingeleitet | Guggenheim | Buy |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-08-07 | Bestätigt | Canaccord Genuity | Buy |
| 2019-04-16 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-04-10 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-02-28 | Bestätigt | BofA/Merrill | Neutral |
| 2018-10-29 | Eingeleitet | BofA/Merrill | Neutral |
| 2018-10-29 | Eingeleitet | JP Morgan | Overweight |
| 2018-10-29 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Guardant Health Inc Aktie (GH) Neueste Nachrichten
Clinical Labs Hope to Head Off Looming Medicare Cuts - Barron's
Guardant Health (GH): Stifel Raises Price Target to $120.00 | GH Stock News - GuruFocus
Stifel raises Guardant Health stock price target to $120 on growth outlook - Investing.com UK
Aug Swings: How strong is Guardant Health Inc. stock balance sheetJuly 2025 Market Mood & Technical Buy Zone Confirmation - ulpravda.ru
How Guardant Health Inc. stock compares to industry benchmarks2025 EndofYear Setup & Expert Curated Trade Setups - ulpravda.ru
Can Guardant Health Inc. stock continue upward trendWeekly Investment Summary & Reliable Breakout Forecasts - ulpravda.ru
Guardant Health’s Shield Blood Test for Colorectal Cancer Screening Now Available for U.S. Military Members and Families - The Joplin Globe
Will Guardant Health Inc. stock deliver better than expected guidanceTrendline Breakouts & Rapid Wealth Accumulation - ulpravda.ru
Assessing Guardant Health (GH) Valuation After Analyst Upgrades And New Cancer Test Partnerships - Yahoo Finance
Guardant Health stock hits 52-week high at 112.43 USD By Investing.com - Investing.com Nigeria
Guardant Health stock jumps 7% as Evercore downgrades — what investors watch next - TechStock²
GH Virtual Meeting Scheduled by BTIG for January 12 - GuruFocus
Guardant Health (NASDAQ:GH) Stock Rating Lowered by Evercore ISI - MarketBeat
GH: Evercore ISI Group Downgrades Guardant Health While Raising Price Target | GH Stock News - GuruFocus
GH: Guggenheim Raises Price Target for Guardant Health to $115 | - GuruFocus
VIRGINIA RETIREMENT SYSTEMS ET Al Takes Position in Guardant Health, Inc. $GH - MarketBeat
Allspring Global Investments Holdings LLC Makes New $39.52 Million Investment in Guardant Health, Inc. $GH - MarketBeat
What analysts say about Guardant Health Inc stockBear Market Strategies & Explosive Growth Opportunities - earlytimes.in
Calamos Advisors LLC Takes $2.78 Million Position in Guardant Health, Inc. $GH - MarketBeat
Canaccord Names Guardant Health (GH) Top Life Science Pick, Cites Strong Growth and Low Downside - Finviz
Behavioral Patterns of GH and Institutional Flows - Stock Traders Daily
Osaic Holdings Inc. Grows Holdings in Guardant Health, Inc. $GH - MarketBeat
Guardant Health (GH) Jumps to New Record High on Earnings Blowout, Bullish Outlook - MSN
Guardant Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference - The Joplin Globe
Global Healthy Living Foundation and Guardant Health Announce Partnership to Advance Awareness of Early Colorectal Cancer Detection and Improve Access to Screening - The Joplin Globe
Guardant Health, Inc. (GH) Stock Analysis: A Precision Oncology Leader with Robust Growth Potential - DirectorsTalk Interviews
Why a Top Biotech Holder Sold 115,000 Mirum Shares but Still Ended Up With $185 Million on the Line - The Motley Fool
Multiple analysts lift Guardant Health, Inc. (GH) targets on screening and data growth - MSN
Capricorn Fund Managers Ltd Takes $2.26 Million Position in Guardant Health, Inc. $GH - MarketBeat
Guardant Health, Inc. (NASDAQ:GH) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Guardant Health, Inc. (NASDAQ:GH) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Genomics in Cancer Care Market to Reach USD 72.87 Billion by 2033 | - openPR.com
Multiple Analysts Lift Guardant Health, Inc. (GH) Targets on Screening and Data Growth - Yahoo Finance
Guardant Health (GH) Leads Healthcare Stocks with 226.48% YTD Ga - GuruFocus
Guardant Health is the top performing healthcare services stock YTD (GH:NASDAQ) - Seeking Alpha
7 Most Promising Gene Editing Stocks According to Analysts - Insider Monkey
Guardant Health (GH) Receives Buy Rating and $125 Price Target f - GuruFocus
Canaccord Genuity Group Issues Positive Forecast for Guardant Health (NASDAQ:GH) Stock Price - MarketBeat
(GH) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
Why Guardant Health Inc. (5GH) stock could be top winnerWeekly Investment Recap & Weekly Momentum Picks - ulpravda.ru
How Guardant Health Inc. (5GH) stock reacts to stronger dollarGap Up & Weekly Sector Rotation Insights - DonanımHaber
First Week of February 2026 Options Trading For Guardant Health (GH) - Nasdaq
How strong is Guardant Health Inc. stock balance sheetJuly 2025 Highlights & Weekly Breakout Stock Alerts - DonanımHaber
Can Guardant Health Inc. (5GH) stock hold up in economic slowdown2025 Big Picture & Low Drawdown Trading Techniques - DonanımHaber
Insider Sell: Musa Tariq Sells Shares of Guardant Health Inc (GH) - GuruFocus
Guardant Health (GH) CIO reports RSU vesting and tax-share withholding - Stock Titan
Guardant Health Insider Move Sparks Fresh Buzz on Wall Street - TipRanks
[Form 4] Guardant Health, Inc. Insider Trading Activity - Stock Titan
Guardant Health (GH) CMO Craig Eagle reports RSU vesting and tax share sale - Stock Titan
Guardant Health (NASDAQ:GH) Director Sells $11,769.36 in Stock - MarketBeat
Dir Tariq Sells 116 ($11.8K) Of Guardant Health Inc [GH] - TradingView — Track All Markets
Finanzdaten der Guardant Health Inc-Aktie (GH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.12%
0.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):